Cargando…

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis

Recent evidence suggests that interleukin (IL)-13 is a crucial cytokine involved in the pathogenesis of atopic dermatitis (AD). It is a central driver of type-2 T-helper inflammation and is overexpressed in lesional skin of AD patients. Upon release in peripheral skin, IL-13 activates its receptors,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Napolitano, Maddalena, di Vico, Francesca, Ruggiero, Angelo, Fabbrocini, Gabriella, Patruno, Cataldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151557/ https://www.ncbi.nlm.nih.gov/pubmed/37144036 http://dx.doi.org/10.3389/fmed.2023.1165098

Ejemplares similares

COVID-19, quarantine, and atopic dermatitis
por: Patruno, Cataldo, et al.
Publicado: (2020)

The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Treatment of Atopic Dermatitis with Biologic Drugs
por: Fabbrocini, Gabriella, et al.
Publicado: (2018)

Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication
por: Napolitano, Maddalena, et al.
Publicado: (2022)

Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report
por: Cantelli, Mariateresa, et al.
Publicado: (2022)

Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review
por: Napolitano, Maddalena, et al.
Publicado: (2022)

Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2022)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

Contact allergy in children with and without atopic dermatitis: An Italian multicentre study
por: Bonamonte, Domenico, et al.
Publicado: (2022)

Systemic Treatment of Adult Atopic Dermatitis: A Review
por: Megna, Matteo, et al.
Publicado: (2016)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Prevalence of Chronic Inducible Urticaria in Elderly Patients
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Vitiligo during dupilumab therapy
por: Picone, Vincenzo, et al.
Publicado: (2023)

Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
por: Lytvyn, Yuliya, et al.
Publicado: (2023)

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?
por: Marasca, Claudio, et al.
Publicado: (2020)

An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip
por: Kim, Kyunghee, et al.
Publicado: (2022)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

Overview of atopic dermatitis
por: Kim, Kyu Han
Publicado: (2013)

Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics
por: Ruggiero, Angelo, et al.
Publicado: (2023)

Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro
por: TOLLENAERE, Maxim A. X., et al.
Publicado: (2021)

Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
por: Marasca, Claudio, et al.
Publicado: (2022)

Probiotics and Atopic Dermatitis: An Overview
por: Rather, Irfan A., et al.
Publicado: (2016)

Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
por: Napolitano, Maddalena, et al.
Publicado: (2017)

The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature
por: Cacciapuoti, Sara, et al.
Publicado: (2020)

Delayed urticaria after the third dose of mRNA COVID19 vaccine: A case series
por: Bianchi, Leonardo, et al.
Publicado: (2022)

The Role of Photoprotection in Optimizing the Treatment of Atopic Dermatitis
por: Piquero-Casals, Jaime, et al.
Publicado: (2021)

Atopic Dermatitis; Etio-Pathogenesis, An Overview
por: Sehgal, Virendra N, et al.
Publicado: (2015)

Atopic Dermatitis—Beyond the Skin
por: Mocanu, Mădălina, et al.
Publicado: (2021)

Skin Microbiota in Atopic Dermatitis
por: Hrestak, Dora, et al.
Publicado: (2022)

Skin Dialogues in Atopic Dermatitis
por: Porumb-Andrese, Elena, et al.
Publicado: (2022)

Skin Microbiome in Atopic Dermatitis
por: EDSLEV, Sofie M., et al.
Publicado: (2020)

Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17
por: Yuki, Takuo, et al.
Publicado: (2016)

The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders
por: Caiazzo, Giuseppina, et al.
Publicado: (2023)

Overview of Atopic Dermatitis in Different Ethnic Groups
por: Chiricozzi, Andrea, et al.
Publicado: (2023)

Role of the skin microbiome in atopic dermatitis
por: Salava, Alexander, et al.
Publicado: (2014)

Atopic Dermatitis: Beyond the Skin and Into the Gut
por: Sadowsky, Rachel L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ef4kb6hnu9srdrj0l8gk6v4e40